Rhumbline Advisers »

Miragen Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 60k 21.78
2023-09-30 $928k 61k 15.34
2023-06-30 $1.4M 60k 23.79
2023-03-31 $1.3M 53k 25.45
2022-12-31 $1.4M 47k 29.20
2022-09-30 $715k 35k 20.51
2022-06-30 $367k 32k 11.57